ADA preview: cardio data in diabetes, drug costs and healthcare reform
Invokana data could suggest cardio benefit for SGLT2 class.
X
ADA preview: cardio data in diabetes, drug costs and healthcare reform
https://pharmaphorum.com/views-and-analysis/ada-preview-new-cardio-data/
